PFIZER INC. Business Summary
- primary care products (72.8%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.;
- specialty care products (13.8%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.;
- oncology products (12.1%);
- other (1.3%).
At the end of 2022, the group had more than 35 manufacturing sites worldwide.
Net sales are distributed geographically as follows: the United States (42.3%), Europe (21.9%) and other (35.8%).
Sales per Business
| USD in Million | 2022 | Weight | 2023 | Weight | Delta |
|---|---|---|---|---|---|
Biopharma
97.8
%
| 98,988 | 98.7 % | 57,186 | 97.8 % | -42.23% |
Other Business Activities
2.2
%
| 1,342 | 1.3 % | 1,310 | 2.2 % | -2.38% |
Sales per region
| USD in Million | 2022 | Weight | 2023 | Weight | Delta |
|---|---|---|---|---|---|
United States
46.3
%
| 42,473 | 42.3 % | 27,088 | 46.3 % | -36.22% |
Emerging Markets
20.5
%
| 20,097 | 20.0 % | 11,996 | 20.5 % | -40.31% |
Developed Europe
19.9
%
| 21,982 | 21.9 % | 11,650 | 19.9 % | -47.00% |
Developed Rest of World
7.3
%
| 7,752 | 7.7 % | 4,251 | 7.3 % | -45.16% |
Japan
6.0
%
| 8,026 | 8.0 % | 3,510 | 6.0 % | -56.27% |
Managers
| Managers | Title | Age | Since |
|---|---|---|---|
Albert Bourla
CEO | Chief Executive Officer | 62 | 92-12-31 |
David Denton
DFI | Director of Finance/CFO | 59 | 22-05-01 |
Jeff Settleman
CTO | Chief Tech/Sci/R&D Officer | - | 19-06-30 |
| Chief Tech/Sci/R&D Officer | - | 06-12-31 | |
Lidia Fonseca
CTO | Chief Tech/Sci/R&D Officer | 55 | - |
Aida Habtezion
CTO | Chief Tech/Sci/R&D Officer | - | 20-12-31 |
Rady Johnson
CMP | Compliance Officer | 63 | 93-12-31 |
Mikael Dolsten
CTO | Chief Tech/Sci/R&D Officer | 65 | 09-09-30 |
Maria Rivas
CTO | Chief Tech/Sci/R&D Officer | 60 | 22-08-31 |
| Investor Relations Contact | - | 21-07-18 |
Members of the board
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 66 | 20-03-31 | |
Ronald Blaylock
BRD | Director/Board Member | 64 | 17-02-22 |
Shantanu Narayen
BRD | Director/Board Member | 60 | 13-09-26 |
Suzanne Johnson
BRD | Director/Board Member | 66 | 07-08-31 |
Scott Gottlieb
BRD | Director/Board Member | 51 | 19-06-26 |
Jim Smith
BRD | Director/Board Member | 64 | 14-06-25 |
Helen Hobbs
BRD | Director/Board Member | 71 | 11-12-11 |
James Quincey
BRD | Director/Board Member | 59 | 20-02-26 |
| Director/Board Member | 66 | 15-06-24 | |
Albert Bourla
CEO | Chief Executive Officer | 62 | 92-12-31 |
Share class
| Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
|---|---|---|---|---|---|
| Stock A | 1 | 9,591,592,898 | 5,663,767,188 ( 59.05 %) | 3,925,000,000 ( 40.92 %) | 59.05 % |
Holdings
| Name | Equities | % | Valuation |
|---|---|---|---|
HALEON PLC 32.36% | 2,955,063,626 | 32.36% | 12,231,510,709 $ |
PFIZER LIMITED 63.92% | 29,243,042 | 63.92% | 1,611,461,224 $ |
| 27,349,211 | 15.01% | 1,114,206,856 $ | |
ARVINAS, INC. 5.05% | 3,457,815 | 5.05% | 114,591,989 $ |
ALLOGENE THERAPEUTICS, INC. 10.55% | 22,032,040 | 10.55% | 55,080,100 $ |
AKERO THERAPEUTICS, INC. 3.65% | 2,525,252 | 3.65% | 47,525,243 $ |
VALNEVA 6.86% | 9,549,761 | 6.86% | 42,650,761 $ |
PYXIS ONCOLOGY, INC. 11.94% | 7,032,770 | 11.94% | 26,302,560 $ |
PYXIS ONCOLOGY, INC. 4.96% | 1,272,214 | 4.96% | 17,518,387 $ |
NXERA PHARMA CO., LTD. 2.10% | 1,885,136 | 2.10% | 17,418,412 $ |
Company contact information
Group companies
| Name | Category and Sector |
|---|---|
Wyeth Holdings LLC
 Wyeth Holdings LLC Chemicals: AgriculturalProcess Industries Wyeth Holdings LLC manufactures and distributes chemicals. The firm's chemical contains phosphate rock, calcium, lime, carbide and nitrogen which are used in fertilizers. The company was founded by Frank Washburn in 1907 and is headquartered in Wayne, NJ. |
Chemicals: Agricultural
|
Genetics Institute LLC
 Genetics Institute LLC Pharmaceuticals: MajorHealth Technology Genetics Institute LLC develops pharmaceutical products through recombinant DNA and other genetic technologies. It develops drugs to make the blood of hemophiliacs clot, as well as substances that stimulate the production of red and white blood cells and proteins that enhance bone growth. The company was founded in 1980 and is headquartered in Cambridge, MA. |
Pharmaceuticals: Major
|
Wyeth Pharmaceuticals LLC
 Wyeth Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Wyeth Pharmaceuticals LLC develops pharmaceutical, biotechnology and vaccine technologies. The company was registered on May 5, 2003 and is headquartered in Collegeville, PA. |
Pharmaceuticals: Major
|
Thiakis Ltd.
 Thiakis Ltd. Pharmaceuticals: MajorHealth Technology Thiakis Ltd. develops hormone-based treatments for obesity and other metabolic diseases. It focuses to commercialize an effective anti-obesity treatment based on a peptide hormone called oxyntomodulin. The company was founded in 2004 by Steve Bloom and John Burt and is headquartered in Sandwich, the United Kingdom. |
Pharmaceuticals: Major
|
Pharmaceuticals: Major
| |
Pfizer Manufacturing Ireland Unlimited Co.
 Pfizer Manufacturing Ireland Unlimited Co. Pharmaceuticals: MajorHealth Technology Pfizer Manufacturing Ireland manufactures and exports pharmaceutical products. It offers formulation and manufacture of human pharmaceuticals and animal health care products. Its Dublin plant manufactures sterile pharmaceutical products. The company was founded in 1969 and is headquartered in Dublin, Ireland. |
Pharmaceuticals: Major
|
Wyeth Consumer Healthcare, Inc.
 Wyeth Consumer Healthcare, Inc. Pharmaceuticals: MajorHealth Technology Wyeth Consumer Healthcare, Inc. discovers, develops and manufactures health care products. The company is headquartered in Mississauga, Canada. |
Pharmaceuticals: Major
|
Ferrosan ApS
 Ferrosan ApS Pharmaceuticals: OtherHealth Technology Ferrosan ApS manufactures and sells pharmaceutical products. Its products include herbal medicine, natural remedies, food supplements, and medical devices. The company was founded by Niels Jacob Herman Weitzmann in 1920 and is headquartered in Ballerup, Denmark. |
Pharmaceuticals: Other
|
John Wyeth & Brother Ltd.
 John Wyeth & Brother Ltd. Pharmaceuticals: MajorHealth Technology John Wyeth & Bros Ltd. manufactures pharmaceutical products. Its products include protein therapeutics, the rheumatoid arthritis treatment Enbrel, the influenza vaccines Begrivac, and Agrippal medications for depression, hemophilia, cancer and bacterial infections. The company was founded in 1960 by John Wyeth and is headquartered in Taplow, the United Kingdom. |
Pharmaceuticals: Major
|
Sector
Sales per Business
Sales per region
| 1st Jan change | Capi. | |
|---|---|---|
| +41.96% | 630B | |
| -7.15% | 350B | |
| +18.77% | 328B | |
| +8.79% | 298B | |
| +18.02% | 246B | |
| +1.27% | 225B | |
| +11.95% | 218B | |
| +3.68% | 160B | |
| -3.71% | 116B |
